Masterson Richard Kevin 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Aug 15, 2011
Insider Transaction Report
Form 4
Masterson Richard Kevin
Pres.&COO, Valeant Int.(BB)SRL
Transactions
- Tax Payment
Common Shares, no par value
2011-05-02$52.63/sh−2,036$107,155→ 32,671 total - Exercise/Conversion
Incentive Stock Options (right to purchase)
2011-08-11$9.42/sh+42,469$400,058→ 75,140 total - Exercise/Conversion
Incentive Stock Options (right to purchase)
2011-08-11$9.42/sh−42,469$400,058→ 359,483 totalExercise: $9.42From: 2008-03-08Exp: 2014-08-14→ Common Stock, no par value (42,649 underlying)
Footnotes (2)
- [F1]Common shares withheld from the issuance of common shares to the Reporting Person to satisfy the tax withholding obligations due upon vesting of performance based restricted share units (PSUs) on May 2, 2011.
- [F2]This number represents common shares received upon vesting of PSUs, as well as PSUs that were previously reported in Table I.